Extendicare (TSE:EXE) Price Target Raised to C$39.00 at Royal Bank Of Canada

Key Points

• Royal Bank of Canada raised Extendicare’s price target to C$39 from C$38 and maintained an “outperform” rating, implying 18.83% upside from the prior close.
• Analyst sentiment is broadly positive: Extendicare has an average “Buy” rating and a consensus price target of C$37, with recent targets ranging from C$38 to C$44.
• Shares traded at C$32.82, while the company reported quarterly EPS of C$0.32 on C$611.04 million in revenue. Extendicare’s operations focus on long-term care homes and publicly funded home health services in Canada.

Extendicare (TSE:EXE - Get Free Report) had its target price hoisted by equities research analysts at Royal Bank Of Canada from C$38.00 to C$39.00 in a research note issued to investors on Friday,BayStreet.CA reports. The firm presently has an "outperform" rating on the stock. Royal Bank Of Canada's price target points to a potential upside of 18.83% from the stock's previous close.

A number of other research analysts have also weighed in on EXE. TD raised their price target on shares of Extendicare from C$32.00 to C$39.00 and gave the company a "buy" rating in a research note on Monday, May 11th. National Bank Financial boosted their price objective on Extendicare from C$34.00 to C$40.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 27th. BMO Capital Markets increased their target price on Extendicare from C$30.00 to C$38.00 in a report on Wednesday, May 13th. Canaccord Genuity Group raised their target price on Extendicare from C$37.00 to C$44.00 and gave the company a "buy" rating in a research report on Monday. Finally, Desjardins lowered their price target on Extendicare from C$40.00 to C$39.00 and set a "buy" rating on the stock in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of C$37.00.

Extendicare Price Performance

TSE:EXE traded up C$0.55 during trading hours on Friday, reaching C$32.82. 242,880 shares of the company were exchanged, compared to its average volume of 398,594. The company has a current ratio of 0.75, a quick ratio of 0.98 and a debt-to-equity ratio of 159.54. The stock's 50-day moving average is C$35.30 and its 200-day moving average is C$30.52. The firm has a market cap of C$3.12 billion, a PE ratio of 25.13 and a beta of 1.59. Extendicare has a twelve month low of C$12.64 and a twelve month high of C$39.14.

Extendicare (TSE:EXE - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported C$0.32 earnings per share (EPS) for the quarter. The business had revenue of C$611.04 million for the quarter. Extendicare had a net margin of 6.13% and a return on equity of 36.33%. On average, sell-side analysts anticipate that Extendicare will post 0.6134729 earnings per share for the current fiscal year.

About Extendicare

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source